Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-067 vs GAAP Ofteno in Primary Open-Angle Glaucoma or Ocular Hypertension
NCT02801617Phase 3Terminated
- Sponsor
- Laboratorios Sophia
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of PRO-067 in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Laboratorios Sophia. Started Sep 2015; status: terminated.
02
Drugs
PRO-067
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02801617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801617.